Back

PAR2 genetic variation stratifies biomarker dynamics and rehospitalisation risk after acute heart failure

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: biomarkers, imaging, and digital prediction of outcomes Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Emily Ghanbari

German Heart Centre Berlin, Berlin (Germany)

6 More presentations in this session

Presentation thumbnail
Interleukin-6 and renal outcomes after heart failure hospitalization: a post-hoc analysis of the JROADHF-NEXT
Doctor Y. Akama (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Voice monitoring to predict heart failure decompensation using AI-based analysis: insights from the Pre-DETECT HF Study
Doctor S. Kabak (Maastricht, NL)
Abstract Slides
Presentation thumbnail
Biomarker-guided early heart failure assessment in hospitalized patients with tachypnea: results from the Akershus Cardiac Examination 4 Study
Doctor R. Bhatnagar (Oslo, NO)
Abstract Slides
Presentation thumbnail
Distinct metabolipidomic signatures differentiate de novo acute heart failure from decompensated chronic heart failure
Doctor M. Tkaczyszyn (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Echocardiography and guideline-directed medical care after abnormal outpatient B-type natriuretic peptide testing in those without pre-existing heart failure
Doctor W. Douglas (Toronto, CA)
Abstract Slides

Access the full session

Session thumbnail
Acute heart failure: biomarkers, imaging, and digital prediction of outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical study of 92 biomarkers
29 June 2021
thumbnail
Congress Presentation
Allelic polymorphism gene ADP receptor R2RY12 T-744C in patients with HFpEF
29 June 2021
thumbnail
Congress Presentation
Investigating the role of protease-activated receptor 2 in adverse cardiac remodeling and clinical outcomes in heart failure: insights from translational research
1 September 2025
thumbnail
Congress Presentation
A Genome-Wide Association Study (GWAS) of Takotsubo syndrome
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources